Lymphoma,Other Cancers Liso-cel in R/R CLL/SLL: Primary Analysis of TRANSCEND CLL 004 Study Jul 31, 2023
Lymphoma,Other Cancers Frontline Intensified ABVD Outperforms PET-Adapted ABVD in Advanced HL Jul 31, 2023
Lymphoma,Other Cancers Pembrolizumab as First Treatment for CHL in Older or ABVD-Ineligible Patients Jul 27, 2023
Lymphoma,Other Cancers Baseline PET Radiomics Predicts PMBCL Better Than Clinical Risk Scores Jul 27, 2023
Lymphoma,Other Cancers CAR-T Cell Therapy for R/R CNS T-Cell Lymphoblastic Leukemia/Lymphoma Jul 14, 2023
Lymphoma,Other Cancers Promising Results of UCART19 in High-Risk Adult B-Cell ALL: CALM Study Jun 30, 2023
Lymphoma,Other Cancers Liso-cel in Relapsed/Refractory LBCL: Correlation of Expansion, Efficacy, and Safety Jun 30, 2023
